(Q46066242)

19 December 2017

editorial

0 references

review article

1 reference

title

Left ventricular hypertrophy in renal disease: beyond preload and afterload (English)

1 reference

19 December 2017

left ventricular hypertrophy

main subject

1 reference

1 reference

Eberhard Ritz

1

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

19 December 2017

published in

Kidney International

1 reference

19 December 2017

volume

75

1 reference

19 December 2017

issue

8

1 reference

19 December 2017

page(s)

771-773

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2009.35

exact match

0 references

cites work

Myocardial hypertrophy in rats with renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Hypertrophy of the heart: a new therapeutic target?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Effects of Moderate Uremia on Cardiac Contractile Responses

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Rapamycin attenuates load-induced cardiac hypertrophy in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Sirolimus treatment of left ventricular hypertrophy: who, and when?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

mTOR pathway as a target in tissue hypertrophy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Toward microRNA-based therapeutics for heart disease: the sense in antisense

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Control of cardiac growth by histone acetylation/deacetylation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.35

7 January 2021

Identifiers

DOI

10.1038/KI.2009.35

1 reference

19 December 2017

1 reference

19 December 2017